FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044335440> ?p ?o ?g. }

• W2044335440 endingPage "3106" @default.
• W2044335440 startingPage "3099" @default.
• W2044335440 abstract "Previous research has shown oprelvekin (recombinant human interleukin-11 [rhIL-11]) to be effective in reducing the requirements for platelet transfusions after myelosuppressive chemotherapy in patients who have previously experienced thrombocytopenia. The economic consequences of the routine use of this platelet growth factor and the usual standard of platelet transfusions for prophylaxis of severe chemotherapy-induced thrombocytopenia have not been compared.The authors constructed a decision-analytic model to compare the alternatives of rhIL-11 versus usual care using probability, outcome, and cost data from previously published clinical trials and their own institutional sources. They incorporated the costs of platelet transfusions and adverse events from rhIL-11 into the analysis. Quality-of-life outcomes were not considered. The pharmacoeconomic analysis was based on the criterion of cost minimization from the payer's perspective.The expected cost of the usual care strategy for prophylaxis of severe thrombocytopenia (transfusion when platelets < 20000 microL(-1)) was US dollars 3495 for a 3-week cycle of chemotherapy. The prophylactic rhIL-11 strategy was more expensive, with an expected cost of US dollars 5328 over the same time period. Nonetheless, it was associated with fewer platelet transfusions, avoiding an average of 6.7 U compared with usual care. The savings from avoidance of platelet transfusion and adverse reactions to transfusion from the use of rhIL-11 were not offset by the substantial cost of the pharmaceutical. The greater expected costs from the rhIL-11 strategy were relatively insensitive to the unit price and efficacy of rhIL-11 and the costs of platelet transfusions and monitoring.From the payer's perspective, rhIL-11 cannot be considered a cost-saving clinical strategy compared with routine platelet transfusions for patients with severe chemotherapy-induced thrombocytopenia." @default.
• W2044335440 created "2016-06-24" @default.
• W2044335440 creator A5008575977 @default.
• W2044335440 creator A5023768230 @default.
• W2044335440 creator A5035493440 @default.
• W2044335440 creator A5046941316 @default.
• W2044335440 date "2003-05-29" @default.
• W2044335440 modified "2023-10-12" @default.
• W2044335440 title "Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy" @default.
• W2044335440 cites W1831183617 @default.
• W2044335440 cites W1886010324 @default.
• W2044335440 cites W1897475900 @default.
• W2044335440 cites W1964274254 @default.
• W2044335440 cites W2080197909 @default.
• W2044335440 cites W2112255573 @default.
• W2044335440 cites W2135714170 @default.
• W2044335440 cites W2142793775 @default.
• W2044335440 cites W2158441687 @default.
• W2044335440 cites W2165010612 @default.
• W2044335440 cites W2165221590 @default.
• W2044335440 cites W2169047364 @default.
• W2044335440 cites W2177459756 @default.
• W2044335440 cites W2185246391 @default.
• W2044335440 cites W2341309557 @default.
• W2044335440 cites W2409948470 @default.
• W2044335440 cites W3203717762 @default.
• W2044335440 cites W4246496739 @default.
• W2044335440 cites W4250903776 @default.
• W2044335440 cites W4252764851 @default.
• W2044335440 doi "https://doi.org/10.1002/cncr.11447" @default.
• W2044335440 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12784347" @default.
• W2044335440 hasPublicationYear "2003" @default.
• W2044335440 type Work @default.
• W2044335440 sameAs 2044335440 @default.
• W2044335440 citedByCount "45" @default.
• W2044335440 countsByYear W20443354402013 @default.
• W2044335440 countsByYear W20443354402014 @default.
• W2044335440 countsByYear W20443354402015 @default.
• W2044335440 countsByYear W20443354402016 @default.
• W2044335440 countsByYear W20443354402017 @default.
• W2044335440 countsByYear W20443354402019 @default.
• W2044335440 countsByYear W20443354402020 @default.
• W2044335440 countsByYear W20443354402021 @default.
• W2044335440 countsByYear W20443354402022 @default.
• W2044335440 countsByYear W20443354402023 @default.
• W2044335440 crossrefType "journal-article" @default.
• W2044335440 hasAuthorship W2044335440A5008575977 @default.
• W2044335440 hasAuthorship W2044335440A5023768230 @default.
• W2044335440 hasAuthorship W2044335440A5035493440 @default.
• W2044335440 hasAuthorship W2044335440A5046941316 @default.
• W2044335440 hasConcept C112930515 @default.
• W2044335440 hasConcept C126322002 @default.
• W2044335440 hasConcept C177713679 @default.
• W2044335440 hasConcept C197934379 @default.
• W2044335440 hasConcept C2776689292 @default.
• W2044335440 hasConcept C2776694085 @default.
• W2044335440 hasConcept C2778690821 @default.
• W2044335440 hasConcept C3019080777 @default.
• W2044335440 hasConcept C64332521 @default.
• W2044335440 hasConcept C71924100 @default.
• W2044335440 hasConcept C74172505 @default.
• W2044335440 hasConcept C89560881 @default.
• W2044335440 hasConcept C91219811 @default.
• W2044335440 hasConceptScore W2044335440C112930515 @default.
• W2044335440 hasConceptScore W2044335440C126322002 @default.
• W2044335440 hasConceptScore W2044335440C177713679 @default.
• W2044335440 hasConceptScore W2044335440C197934379 @default.
• W2044335440 hasConceptScore W2044335440C2776689292 @default.
• W2044335440 hasConceptScore W2044335440C2776694085 @default.
• W2044335440 hasConceptScore W2044335440C2778690821 @default.
• W2044335440 hasConceptScore W2044335440C3019080777 @default.
• W2044335440 hasConceptScore W2044335440C64332521 @default.
• W2044335440 hasConceptScore W2044335440C71924100 @default.
• W2044335440 hasConceptScore W2044335440C74172505 @default.
• W2044335440 hasConceptScore W2044335440C89560881 @default.
• W2044335440 hasConceptScore W2044335440C91219811 @default.
• W2044335440 hasIssue "12" @default.
• W2044335440 hasLocation W20443354401 @default.
• W2044335440 hasLocation W20443354402 @default.
• W2044335440 hasOpenAccess W2044335440 @default.
• W2044335440 hasPrimaryLocation W20443354401 @default.
• W2044335440 hasRelatedWork W2016595804 @default.
• W2044335440 hasRelatedWork W2030460291 @default.
• W2044335440 hasRelatedWork W2065328143 @default.
• W2044335440 hasRelatedWork W2089577000 @default.
• W2044335440 hasRelatedWork W2109087839 @default.
• W2044335440 hasRelatedWork W2386686048 @default.
• W2044335440 hasRelatedWork W2387587816 @default.
• W2044335440 hasRelatedWork W2423661781 @default.
• W2044335440 hasRelatedWork W2978727189 @default.
• W2044335440 hasRelatedWork W3031184024 @default.
• W2044335440 hasVolume "97" @default.
• W2044335440 isParatext "false" @default.
• W2044335440 isRetracted "false" @default.
• W2044335440 magId "2044335440" @default.
• W2044335440 workType "article" @default.